• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of and finding treatments for complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia (FM), long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To register, simply click the Register button at the top right.

FDA CFS and ME Teleconference - October 16, 2013

Denise

Senior Member
Messages
1,095
  1. In case you have not seen it, FDA has produced a report based on the April 25th meeting. You can download it or read it here http://www.fda.gov/downloads/ForIndustry/UserFees/PrescriptionDrugUserFee/UCM368806.pdf. Based on the input received at the meeting and from material submitted to the docket, their characterization of ME is quite good.
  2. As a followup to the April FDA meeting, FDA is hosting a teleconference on Wednesday Oct 16th fro 1:30-3pm (eastern time). Details below.

On October 16 from 1:30 PM – 3:00 PM EST, FDA will hold a teleconference that is open to the public. FDA will provide introductory and background remarks then the teleconference will be open for public comment on the following three topics:
1. Feedback from the CFS and ME public workshop.
2. Current projects related to drug development in CFS and ME.
3. Potential methods to catalyze CFS and ME drug development.

Registration (Closes October 11, 2013): https://cfsmeteleconference2013.eventbrite.com/

FDA CFS and ME Activities Website: http://www.fda.gov/Drugs/NewsEvents/ucm319188.htm

Please contact Randi Clark (Randi.Clark@fda.hhs.gov) or Mary Gross (Mary.Gross@fda.hhs.gov) if you have any questions.
 

Simon

Senior Member
Messages
3,789
Location
Monmouth, UK
Registered - and can record if I can access by Skype, but don't have time to write. Anyone know how 'phoning in' works, or is it actually online?
 

WillowJ

คภภเє ɠรค๓թєl
Messages
4,940
Location
WA, USA
I have an e-ticket with a barcode--instructions say to print it (as, on paper) and bring it with me to the door--which I'm sure will be very useful over the telephone and internet :rofl:
 

beaker

ME/cfs 1986
Messages
773
Location
USA
I just saw this and therefore missed the sign up. Will someone be taking notes and /or recording ? Would be much appreciated. Thanks.
 

Nielk

Senior Member
Messages
6,970
Agenda

Chronic Fatigue Syndrome (CFS) and Myalgic Encephalomyelitis (ME) Teleconference
October 16, 2013
1:30 PM – 3:00 PM EST

Dial‐In: 1‐888‐324‐9559
Password: CFS

1:30 PM Introductions and Opening Remarks
RADM Sandra Kweder, MD
Deputy Director, Office of New Drugs
Center for Drug Evaluation and Research
U.S. Food and Drug Administration

1:50 PM Topic 1: CFS and ME Public Workshop Feedback
Dial *1 to be placed in the queue for comment.

2:10 PM Topics 2 and 3: Current Projects Related to Drug Development in CFS and ME and
Potential Methods to Catalyze CFS and ME Drug Development
Dial *1 to be placed in the queue for comment.

2:50 PM Closing Comments RADM Sandra Kweder, MD
 

beaker

ME/cfs 1986
Messages
773
Location
USA
I slept through it.
I look forward to anything anyone can share from it.

Thank you .
 

Nielk

Senior Member
Messages
6,970
I listened in but, I had a huge headache and could not concentrate.

They had a few FDA members there as a panel.

They had a short re-cap of the 2 day April meeting. They kept saying how successful it was and how they were happy with the positive feedback from patients.

They introduced the new CGSAC FDA ex-officio. her name is Janet Maner (sic?)

They said that ME/CFS is a serious disease with no approved therapies. It represents a public health concern.
They are working on a "guidance document" which will help pharmaceutical companies who want to work on finding treatments. It will help catalyze drug development.

A lot of time was allotted to question/comments from the listeners.

Questions from doctors, care takers, patients, one pharmaceutical representative (Eli Lilly), advocates.

Enlander asked about how to get approval for clinicians to use Rituximab. I'm not sure what the answer was but I think they said that sometimes this can best achieved through the maker of the drug.

I remember a question about how the IOM contract for definition will effect them. They said that it's great to have such a respectable institute work on a clear definition. This will help the pharmaceutical companies to know what is needed.

My brain is freezing now...maybe someone else can continue?
 

Nielk

Senior Member
Messages
6,970
I remember an important question/comment about the fact that the FDA panel for ME/CFS drugs would be knowledgeable about the disease. It was asked because at the Ampligen debate, the panel was pretty much ignorant to the disease.

The reply was that the problem is that panel members cannot have a bias. For example anyone who had or was involved in any study of the disease has to be ruled out!

Think about what this application means for the IOM fiasco.
 

Firestormm

Senior Member
Messages
5,055
Location
Cornwall England
I remember an important question/comment about the fact that the FDA panel for ME/CFS drugs would be knowledgeable about the disease. It was asked because at the Ampligen debate, the panel was pretty much ignorant to the disease.

The reply was that the problem is that panel members cannot have a bias. For example anyone who had or was involved in any study of the disease has to be ruled out!

Think about what this application means for the IOM fiasco.

I have access to a recording, if I get time and it's worth doing, I'll transcribe.
 

Bob

Senior Member
Messages
16,455
Location
England (south coast)
The reply was that the problem is that panel members cannot have a bias. For example anyone who had or was involved in any study of the disease has to be ruled out!

Think about what this application means for the IOM fiasco.

Yes, this is a very worrying aspect of the IOM contract.
If none of the panel members have any in-depth or first-hand knowledge of ME, then I can only anticipate that the whole process will be an unmitigated disaster.